GamaMabs Pharma SA
Industry
- Biotechnology
Latest on GamaMabs Pharma SA
Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AstraZeneca To Study ‘Elite Controller’
A glyco-engineered antibody from French firm GamaMabs Pharma SA has demonstrated longer than expected progression-free survival rates in patients with metastatic colorectal cancer also treated with
Antibodies Evolve At the cutting edge of a mature field, new players strive to improve upon existing therapeutic antibodies. Methods for discovering and developing drugs of this kind are evolving alo
César Milstein was recognized with the Nobel Prize in Physiology or Medicine in 1984, along with Georges Köhler, a postdoctoral fellow in his lab, for developing the hybridoma technique for producing